Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension

Novartis Investigative Site, Lynbrook

Novartis Investigative Site, Bethpage

Novartis Investigative Site, Rochester

Novartis Investigative Site, Charlotte

Novartis Investigative Site, Charlotte

Novartis Investigative Site, Mt. Pleasant

Novartis Investigative Site, Roswell

Novartis Investigative Site, Morrow

Novartis Investigative Site, Atlanta

Novartis Investigative Site, Memphis

Novartis Investigative Site, Louisville

Novartis Investigative Site, Springfield

Novartis Investigative Site, Topeka

Novartis Investigative Site, Omaha

Novartis Investigative Site, Bossier City

Novartis Investigative Site, Tulsa

Novartis Investigative Site, Houston

Novartis Investigative Site, San Antonio

Novartis Investigative Site, El Paso

Novartis Investigative Site, Las Vegas

Novartis Investigative Site, Inglewood

Novartis Investigative Site, Artesia

Novartis Investigative Site, La Jolla

Novartis Investigative Site, Poway

Novartis Investigative Site, Stockton

Novartis Investigative Site, Kaneohe

Novartis Investigative Site, Spokane

Novartis Investigative Site, Danbury

Novartis Investigative Site, Cambridge